DPP-4 Inhibitor Linagliptin vs Sulfonylurea Glimepiride as Add-On to Metformin on Renal Physiology in Overweight Patients With T2DM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-On to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial
Diabetes Care 2020 Sep 08;[EPub Ahead of Print], MHA Muskiet, L Tonneijck, MM Smits, MHH Kramer, DM Ouwens, B Hartmann, JJ Holst, DJ Touw, AHJ Danser, JA Joles, DH van RaalteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.